Analystreport

Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target lowered by analysts at Guggenheim from $114.00 to $101.00.

Krystal Biotech, Inc.  (KRYS) 
Last krystal biotech, inc. earnings: 11/4 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.krystalbio.com/investors